⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

November 20, 2020JAMA Network OpenOpen Access

Statins and LDL-C in Secondary Prevention—So Much Progress, So Far to Go

View Full Paper

Ask AI

Bookmark

Share

Abstract

Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Banach et al. (2020) studied this question.

synapsesocial.com/papers/6ab7709aa7ca538b97a6f491 https://doi.org/10.1001/jamanetworkopen.2020.25675

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016Cohort Study · 2020 · 114 citations
2Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panelguideline · 2015 · 161 citations
3Introducing the ‘Drucebo’ effect in statin therapy: a systematic review of studies comparing reported rates of statin‐associated muscle symptoms, under blinded and open‐label conditionsMeta-Analysis · 2018 · 110 citations
42019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>Original Research · 2019 · 9,166 citations
52020 Guidelines of the Polish Society of Laboratory Diagnostics (PSLD) and the Polish Lipid Association (PoLA) on laboratory diagnostics of lipid metabolism disordersOriginal Research · 2020 · 63 citations